• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to navigation
Close Ad

The Spoon

Daily news and analysis about the food tech revolution

  • Home
  • Podcasts
  • Events
  • Newsletter
  • Connect
    • Custom Events
    • Slack
    • RSS
    • Send us a Tip
  • Advertise
  • Consulting
  • About
The Spoon
  • Home
  • Podcasts
  • Newsletter
  • Events
  • Advertise
  • About

cellag

January 26, 2023

New Alt Protein and Bioinnovation Hubs Are Popping Up From NYC to Israel

This week was a big one when it came to incubating the next generation of future food.

Not only did GFI Israel and Technion announce a new Sustainable Protein Research Center (SPRC), but the city of New York also announced it would build a “bioinnovation hub” with $20 million in new funding earmarked from NYC Mayor Eric Adams’ administration.

The SPRC, which Technion and GFI Israel claim is the first of its kind in the world, “will coordinate the collaborative activities of dozens of researchers from more than ten different academic departments at the Technion and with additional universities and companies to address the world’s most pressing challenges of sustainability and human health.”

The new facility will have a 5-year budget of $20 million and will facilitate the recruitment of new faculty members in the field and support “the construction of a building for the Carasso FoodTech Innovation Center.” The new center will purchase and maintain capital equipment and recruit professional technicians and ” fund collaborative seed research and train graduate students and post-docs in related fields.”

Closer to home, the new Center for Planetary Health (C4PH) will be built next to Brooklyn’s Navy Shipyard as part of Newlab, a cross-industry innovation coworking center, and venture studio. The new C4PH will be funded by $20 million allocated as part of the LifeSci NYC initiative, a broad new push that is part of NYC Mayor Eric Adams’ “Working People Agenda.”

Adams commented on the new investment as part of the state of the city address.

“We’re also investing in the jobs of the future,” said Adam. “Last year, Governor Hochul and I announced a new life sciences hub in Kips Bay, which will create 10,000 jobs and $25 billion in economic impact. And this year, the city will kickstart a new effort to become the global center of sustainable biotech.

We will start by opening a first-in-the-nation incubator at the Brooklyn Navy Yard, where biotech startups will transform the way we eat, build, and protect our environment. And as we work to create more jobs, we will also help New Yorkers train for the jobs that are in high demand right now — jobs in tech, renewable energy, and nursing.”

At last week’s Tufts Cellular Agriculture Innovation Summit, several speakers pointed to the need for increased government investment in biotechnology innovation and production infrastructure to help fund the next wave of breakthroughs that will help the future food industry leap forward. While the NYC investment may not do anything to solve the need for the billions of funding needed in production capacity capex the alt-meat industry will need in the future, it’s a sign – much like California’s $5 million allocation last year – that local governments are beginning to understand that investment in the alternative protein industry could make their states more competitive – and create more jobs – when these industries begin high-yield production down the road.

January 23, 2023

What’s Next For Cellular Agriculture: 5 Takeaways From Tufts Cellular Agriculture Innovation Day

Pioneers in cellular agriculture came together in Boston last week to discuss the state of the industry – and what it will take to take cell-cultivated products to the next level.

Tufts University’s inaugural Cellular Agriculture Innovation Day featured panel discussions with industry leaders, researchers, and other experts. The panelists reflected on how far the technology to grow meat and other products has come over the last decade, and shared their visions of how that momentum will continue over the next few years.

A decade ago, “you could count the number of people dedicated to cellular agriculture on one hand,” said Isha Datar, executive director of the research nonprofit New Harvest, in a panel discussion at the event.

“To see 10 years go by, and to see 150 companies pop up, so much private investment pop up, lots more people in the academic space – to me, it’s like, ‘okay, the party has been started,’” Datar said.


All eyes on cell culture media

Cellular agriculture has many research and development hurdles to clear in coming years, said Mark Post, chief scientific officer at Mosa Meats, in a panel discussion.

In particular, the industry still needs to work “quite extensively” on the cost-effectiveness – and in particular, the resource efficiency – of its manufacturing processes, Post said.

The biggest cost driver for cell-cultivated products today is culture media: the nutrient-rich material that supports the growth of cells.

According to Andrew Stout, a PhD student focusing on cultivated cell lines and culture media at Tufts University, the cellular agriculture field has already seen success in cutting costs for some culture media components, such as growth factors.

Those components were the “low-hanging fruit” of culture media, Stout said at the event.

Moving forward, researchers in the field will likely address “the next lowest fruit,” such as amino acids and vitamins, he said.


Collaborating to solve key questions

Datar, the executive director at New Harvest, forecast that industry players will increasingly find answers to their questions by working together.

Much of the news from the industry in recent years has concerned individual companies and products – but over the next decade, we’ll hear more about how different companies and other players are working together to “solve [the] puzzle,” Datar said.

In particular, companies collaboratively address the challenge of scaling up using shared facilities, she said.

In 2021, we saw an announcement for one such facility in Europe: the Cultured Food Innovation Hub planned by Swiss flavor manufacturer Givaudan and other partners. The companies planned the Innovation Hub as a space for startups to access shared equipment, enabling more players to innovate in the field at lower cost.


Securing public funding

Bruce Friedrich, president and co-founder of the Good Food Institute, forecast that public funding will play an increasingly important role in helping the industry to address challenges of cost and scale.

In the last three years, governments around the world have already “gone from almost zero to hundreds of millions of dollars” in funding, Friedrich said.

Friedrich laid out a vision of government funding for cellular agriculture that would mirror investments in renewable energy and electric vehicles.

In the U.S., there could be bipartisan support for spending to support the industry, he said – pointing to efforts by the Good Food Institute to communicate with Republican lawmakers about the potential employment and economic benefits of such spending.


Introducing cell-cultivated products to the public

The speakers at the Tufts event also addressed the need to continue improving cell-cultivated products themselves before introducing them to consumers.

For Post, the chief scientific officer at Mosa Meats, one step to improve product quality could be improving the differentiation of muscle and fat tissues.

Academia can help to improve the quality of cell-cultivated products by identifying which genetic features can identify cells that will produce tasty end-products, according to Stout, the PhD student at Tufts University.

According to David Block, a professor of chemical engineering at the University of California, Davis, another task for academia will be to ensure that cell-cultivated products are nutritionally equivalent to their conventional equivalents.

But the industry also has “an opportunity” to take more control over the nutritional quality and safety of its products than conventional agriculture, because cell-cultivated products are grown in much more controlled environments, Block said in a panel discussion at the event.


Moving toward semi-industrialization

The industry has begun to receive its first regulatory stamps of approval, and is “at the verge of getting regulatory approval in a lot of geographies,” according to Post.

In November, UPSIDE Foods became the first company to receive a “no questions” letter from the FDA – meaning the agency determined that the company’s cell-cultivated chicken is safe for consumers.

Eat Just, a San-Francisco startup, became the first company to receive regulatory approval for cell-cultivated meat when the Singapore Food Agency green-lit its cell-cultivated chicken in 2020.

With regulatory clearance in the works, and factories beginning to be built, “we are really getting to the level where [the industry] becomes sort of semi-industrial,” Post said.

But he added: “It will take a long time before [cell-cultivated products] will be a substantial part of markets where eventually we can make an impact on the environment, which is the root of all this.”

Uma Valeti, chief executive officer of UPSIDE Foods, said that it could be between 10 and 30 years before cultivated meat “takes off.”

March 10, 2022

SuperMeat Partners With Japanese Food Giant Ajinomoto To Scale Cultivated Meat Production

SuperMeat, a cell-cultured meat company based in Israel, and Ajinomoto, a large Japanese food and biotechnology conglomerate, announced today the formation of a strategic partnership to “to establish a commercially viable supply chain platform for the cultivated meat industry.”

According to the announcement, the partnership, which will include an investment by Ajinomoto in SuperMeat, will combine SuperMeat’s expertise in cultivated meat with Ajinomoto’s R&D technology and expertise in biotech and fermentation capabilities.

One of the main focuses of the new partnership will be in the development of cell-cultured growth media, the broth which contains the nutrients needed for animal cell growth, which remains one of the biggest overall cost drivers in the creation of cultivated meat. According to a study by the Good Food Institute conducted in 2020 of cultivated meat producers, 72% of respondents indicated that cell growth media represented over 50% of their operating costs, and 38% said growth media represented 80% or more of operating costs. By combining SuperMeat’s technology advancements in cultivated meat with Anjinomoto’s biomanufacturing expertise, the two companies hope to drive down costs while increasing the supply of food-grade growth factors.

Anjinomoto’s partnership is a further signal of the interest by the Japan food industry in cell-cultured meat production. A number of Japanese investment funds recently participated in a $7 million investment round in Integriculture, one of Japan’s cultured meat pioneers, and before that Aleph Farms joined up with Mitsubishi to work on bringing cultured meat to the country. This interest in accelerating Japan’s cultivated meat industry is not surprising given the country’s historically low food self-sufficiency. Other countries with limited internal agriculture such as Singapore and Israel have identified future food sources like cultivated meat as strategically important, and Japan is following suit.

Primary Sidebar

Footer

  • About
  • Sponsor the Spoon
  • The Spoon Events
  • Spoon Plus

© 2016–2025 The Spoon. All rights reserved.

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
 

Loading Comments...